APO Research
Talk to an analyst

APO RESEARCH · REPORT

Donepezil for Alzheimer

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Donepezil for Alzheimer Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchDonepezil for Alzheimer Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Donepezil for Alzheimer Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Donepezil for Alzheimer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Donepezil for Alzheimer Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Donepezil for Alzheimer Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Donepezil for Alzheimer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Donepezil for Alzheimer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Donepezil for Alzheimer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Donepezil for Alzheimer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Donepezil for Alzheimer market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Donepezil for Alzheimer market include Eisai, Teva, Sun Pharmaceutical, Novartis, Luoxin, Jishengtang Pharma, Pfizer, Hansoh Pharma and Dr Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Donepezil for Alzheimer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Donepezil for Alzheimer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Donepezil for Alzheimer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Donepezil for Alzheimer market size, projected growth trends, production technologies, key applications, and end-use industries.

Donepezil for Alzheimer Segment by Company

Eisai

Teva

Sun Pharmaceutical

Novartis

Luoxin

Jishengtang Pharma

Pfizer

Hansoh Pharma

Dr Reddy's Laboratories

Cipla

ARK PHA.LTD

Apotex

Donepezil for Alzheimer Segment by Type

5mg

23mg

10mg

Donepezil for Alzheimer Segment by Application

Clinics

Hospitals

Drugstore

Donepezil for Alzheimer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Donepezil for Alzheimer status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Donepezil for Alzheimer market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Donepezil for Alzheimer significant trends, drivers, influence factors in global and regions.

6. To analyze Donepezil for Alzheimer competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil for Alzheimer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Donepezil for Alzheimer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil for Alzheimer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Donepezil for Alzheimer market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Donepezil for Alzheimer industry.

Chapter 3: Detailed analysis of Donepezil for Alzheimer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Donepezil for Alzheimer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Donepezil for Alzheimer in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Donepezil for Alzheimer Industry Trends Table 2. Donepezil for Alzheimer Industry Drivers Table 3. Donepezil for Alzheimer Industry Opportunities and Challenges Table 4. Donepezil for Alzheimer Industry Restraints Table 5. Global Donepezil for Alzheimer Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Donepezil for Alzheimer Revenue Share by Company (2021-2026) Table 7. Global Donepezil for Alzheimer Sales Volume by Company (k units) & (2021-2026) Table 8. Global Donepezil for Alzheimer Sales Volume Share by Company (2021-2026) Table 9. Global Donepezil for Alzheimer Average Price (US$/unit) of Company (2021-2026) Table 10. Global Donepezil for Alzheimer Company Ranking, (2024-2026) & (USD Million) Table 11. Global Donepezil for Alzheimer Key Company Manufacturing Base & Headquarters Table 12. Global Donepezil for Alzheimer Company, Product Type & Application Table 13. Global Donepezil for Alzheimer Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Donepezil for Alzheimer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5mg Table 18. Significant Companies of 23mg Table 19. Significant Companies of 10mg Table 20. Global Donepezil for Alzheimer Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Donepezil for Alzheimer Sales Volume by Type (2021-2026) & (k units) Table 22. Global Donepezil for Alzheimer Sales Volume by Type (2027-2032) & (k units) Table 23. Global Donepezil for Alzheimer Sales Volume Share by Type (2021-2026) Table 24. Global Donepezil for Alzheimer Sales Volume Share by Type (2027-2032) Table 25. Global Donepezil for Alzheimer Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Donepezil for Alzheimer Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Donepezil for Alzheimer Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Donepezil for Alzheimer Sales Value Share by Type (2021-2026) Table 29. Global Donepezil for Alzheimer Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Clinics Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Drugstore Table 33. Global Donepezil for Alzheimer Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Donepezil for Alzheimer Sales Volume by Application (2021-2026) & (k units) Table 35. Global Donepezil for Alzheimer Sales Volume by Application (2027-2032) & (k units) Table 36. Global Donepezil for Alzheimer Sales Volume Share by Application (2021-2026) Table 37. Global Donepezil for Alzheimer Sales Volume Share by Application (2027-2032) Table 38. Global Donepezil for Alzheimer Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Donepezil for Alzheimer Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Donepezil for Alzheimer Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Donepezil for Alzheimer Sales Value Share by Application (2021-2026) Table 42. Global Donepezil for Alzheimer Sales Value Share by Application (2027-2032) Table 43. Global Donepezil for Alzheimer Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Donepezil for Alzheimer Sales by Region (2021-2026) & (k units) Table 45. Global Donepezil for Alzheimer Sales Market Share by Region (2021-2026) Table 46. Global Donepezil for Alzheimer Sales by Region (2027-2032) & (k units) Table 47. Global Donepezil for Alzheimer Sales Market Share by Region (2027-2032) Table 48. Global Donepezil for Alzheimer Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Donepezil for Alzheimer Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Donepezil for Alzheimer Sales Value Share by Region (2021-2026) Table 51. Global Donepezil for Alzheimer Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Donepezil for Alzheimer Sales Value Share by Region (2027-2032) Table 53. Global Donepezil for Alzheimer Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Donepezil for Alzheimer Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Donepezil for Alzheimer Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Donepezil for Alzheimer Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Donepezil for Alzheimer Sales by Country (2021-2026) & (k units) Table 58. Global Donepezil for Alzheimer Sales Market Share by Country (2021-2026) Table 59. Global Donepezil for Alzheimer Sales by Country (2027-2032) & (k units) Table 60. Global Donepezil for Alzheimer Sales Market Share by Country (2027-2032) Table 61. Global Donepezil for Alzheimer Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Donepezil for Alzheimer Sales Value Market Share by Country (2021-2026) Table 63. Global Donepezil for Alzheimer Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Donepezil for Alzheimer Sales Value Market Share by Country (2027-2032) Table 65. Eisai Company Information Table 66. Eisai Business Overview Table 67. Eisai Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Eisai Donepezil for Alzheimer Product Portfolio Table 69. Eisai Recent Development Table 70. Teva Company Information Table 71. Teva Business Overview Table 72. Teva Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Teva Donepezil for Alzheimer Product Portfolio Table 74. Teva Recent Development Table 75. Sun Pharmaceutical Company Information Table 76. Sun Pharmaceutical Business Overview Table 77. Sun Pharmaceutical Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Sun Pharmaceutical Donepezil for Alzheimer Product Portfolio Table 79. Sun Pharmaceutical Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Novartis Donepezil for Alzheimer Product Portfolio Table 84. Novartis Recent Development Table 85. Luoxin Company Information Table 86. Luoxin Business Overview Table 87. Luoxin Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Luoxin Donepezil for Alzheimer Product Portfolio Table 89. Luoxin Recent Development Table 90. Jishengtang Pharma Company Information Table 91. Jishengtang Pharma Business Overview Table 92. Jishengtang Pharma Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Jishengtang Pharma Donepezil for Alzheimer Product Portfolio Table 94. Jishengtang Pharma Recent Development Table 95. Pfizer Company Information Table 96. Pfizer Business Overview Table 97. Pfizer Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Pfizer Donepezil for Alzheimer Product Portfolio Table 99. Pfizer Recent Development Table 100. Hansoh Pharma Company Information Table 101. Hansoh Pharma Business Overview Table 102. Hansoh Pharma Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Hansoh Pharma Donepezil for Alzheimer Product Portfolio Table 104. Hansoh Pharma Recent Development Table 105. Dr Reddy's Laboratories Company Information Table 106. Dr Reddy's Laboratories Business Overview Table 107. Dr Reddy's Laboratories Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Dr Reddy's Laboratories Donepezil for Alzheimer Product Portfolio Table 109. Dr Reddy's Laboratories Recent Development Table 110. Cipla Company Information Table 111. Cipla Business Overview Table 112. Cipla Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Cipla Donepezil for Alzheimer Product Portfolio Table 114. Cipla Recent Development Table 115. ARK PHA.LTD Company Information Table 116. ARK PHA.LTD Business Overview Table 117. ARK PHA.LTD Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. ARK PHA.LTD Donepezil for Alzheimer Product Portfolio Table 119. ARK PHA.LTD Recent Development Table 120. Apotex Company Information Table 121. Apotex Business Overview Table 122. Apotex Donepezil for Alzheimer Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Apotex Donepezil for Alzheimer Product Portfolio Table 124. Apotex Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Donepezil for Alzheimer Distributors List Table 128. Donepezil for Alzheimer Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Donepezil for Alzheimer Product Image Figure 2. Global Donepezil for Alzheimer Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Donepezil for Alzheimer Sales Value (2021-2032) & (US$ Million) Figure 4. Global Donepezil for Alzheimer Sales (2021-2032) & (k units) Figure 5. Global Donepezil for Alzheimer Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Donepezil for Alzheimer Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5mg Image Figure 10. 23mg Image Figure 11. 10mg Image Figure 12. Global Donepezil for Alzheimer Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Donepezil for Alzheimer Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Donepezil for Alzheimer Sales Volume Share by Type (2021-2032) Figure 15. Global Donepezil for Alzheimer Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Donepezil for Alzheimer Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Donepezil for Alzheimer Sales Value Share by Type (2021-2032) Figure 18. Clinics Image Figure 19. Hospitals Image Figure 20. Drugstore Image Figure 21. Global Donepezil for Alzheimer Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Donepezil for Alzheimer Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Donepezil for Alzheimer Sales Volume Share by Application (2021-2032) Figure 24. Global Donepezil for Alzheimer Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Donepezil for Alzheimer Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Donepezil for Alzheimer Sales Value Share by Application (2021-2032) Figure 27. Global Donepezil for Alzheimer Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Donepezil for Alzheimer Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Donepezil for Alzheimer Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Donepezil for Alzheimer Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Donepezil for Alzheimer Sales Value (2021-2032) & (US$ Million) Figure 32. North America Donepezil for Alzheimer Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Donepezil for Alzheimer Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Donepezil for Alzheimer Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Donepezil for Alzheimer Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Donepezil for Alzheimer Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Donepezil for Alzheimer Sales Value (2021-2032) & (US$ Million) Figure 38. South America Donepezil for Alzheimer Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Donepezil for Alzheimer Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Donepezil for Alzheimer Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Donepezil for Alzheimer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Donepezil for Alzheimer Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Donepezil for Alzheimer Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 23mg
  • 10mg
Applications
  • Clinics
  • Hospitals
  • Drugstore
Companies covered
  • Eisai
  • Teva
  • Sun Pharmaceutical
  • Novartis
  • Luoxin
  • Jishengtang Pharma
  • Pfizer
  • Hansoh Pharma
  • Dr Reddy's Laboratories
  • Cipla
  • ARK PHA.LTD
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Donepezil for Alzheimer Sales Value (2021-2032)
  4. 1.2.2 Global Donepezil for Alzheimer Sales Volume (2021-2032)
  5. 1.2.3 Global Donepezil for Alzheimer Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Donepezil for Alzheimer Market Dynamics
  1. 2.1 Donepezil for Alzheimer Industry Trends
  2. 2.2 Donepezil for Alzheimer Industry Drivers
  3. 2.3 Donepezil for Alzheimer Industry Opportunities and Challenges
  4. 2.4 Donepezil for Alzheimer Industry Restraints
3 Donepezil for Alzheimer Market by Company
  1. 3.1 Global Donepezil for Alzheimer Company Revenue Ranking in 2025
  2. 3.2 Global Donepezil for Alzheimer Revenue by Company (2021-2026)
  3. 3.3 Global Donepezil for Alzheimer Sales Volume by Company (2021-2026)
  4. 3.4 Global Donepezil for Alzheimer Average Price by Company (2021-2026)
  5. 3.5 Global Donepezil for Alzheimer Company Ranking (2024-2026)
  6. 3.6 Global Donepezil for Alzheimer Company Manufacturing Base and Headquarters
  7. 3.7 Global Donepezil for Alzheimer Company Product Type and Application
  8. 3.8 Global Donepezil for Alzheimer Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Donepezil for Alzheimer Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Donepezil for Alzheimer Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Donepezil for Alzheimer Market by Type
  1. 4.1 Donepezil for Alzheimer Type Introduction
  2. 4.1.1 5mg
  3. 4.1.2 23mg
  4. 4.1.3 10mg
  5. 4.2 Global Donepezil for Alzheimer Sales Volume by Type
  6. 4.2.1 Global Donepezil for Alzheimer Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Donepezil for Alzheimer Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Donepezil for Alzheimer Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Donepezil for Alzheimer Sales Value by Type
  10. 4.3.1 Global Donepezil for Alzheimer Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Donepezil for Alzheimer Sales Value by Type (2021-2032)
  12. 4.3.3 Global Donepezil for Alzheimer Sales Value Share by Type (2021-2032)
5 Donepezil for Alzheimer Market by Application
  1. 5.1 Donepezil for Alzheimer Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Drugstore
  5. 5.2 Global Donepezil for Alzheimer Sales Volume by Application
  6. 5.2.1 Global Donepezil for Alzheimer Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Donepezil for Alzheimer Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Donepezil for Alzheimer Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Donepezil for Alzheimer Sales Value by Application
  10. 5.3.1 Global Donepezil for Alzheimer Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Donepezil for Alzheimer Sales Value by Application (2021-2032)
  12. 5.3.3 Global Donepezil for Alzheimer Sales Value Share by Application (2021-2032)
6 Donepezil for Alzheimer Regional Sales and Value Analysis
  1. 6.1 Global Donepezil for Alzheimer Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Donepezil for Alzheimer Sales by Region (2021-2032)
  3. 6.2.1 Global Donepezil for Alzheimer Sales by Region: 2021-2026
  4. 6.2.2 Global Donepezil for Alzheimer Sales by Region (2027-2032)
  5. 6.3 Global Donepezil for Alzheimer Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Donepezil for Alzheimer Sales Value by Region (2021-2032)
  7. 6.4.1 Global Donepezil for Alzheimer Sales Value by Region: 2021-2026
  8. 6.4.2 Global Donepezil for Alzheimer Sales Value by Region (2027-2032)
  9. 6.5 Global Donepezil for Alzheimer Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Donepezil for Alzheimer Sales Value (2021-2032)
  12. 6.6.2 North America Donepezil for Alzheimer Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Donepezil for Alzheimer Sales Value (2021-2032)
  15. 6.7.2 Europe Donepezil for Alzheimer Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Donepezil for Alzheimer Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Donepezil for Alzheimer Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Donepezil for Alzheimer Sales Value (2021-2032)
  21. 6.9.2 South America Donepezil for Alzheimer Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Donepezil for Alzheimer Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Donepezil for Alzheimer Sales Value Share by Country, 2025 VS 2032
7 Donepezil for Alzheimer Country-level Sales and Value Analysis
  1. 7.1 Global Donepezil for Alzheimer Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Donepezil for Alzheimer Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Donepezil for Alzheimer Sales by Country (2021-2032)
  4. 7.3.1 Global Donepezil for Alzheimer Sales by Country (2021-2026)
  5. 7.3.2 Global Donepezil for Alzheimer Sales by Country (2027-2032)
  6. 7.4 Global Donepezil for Alzheimer Sales Value by Country (2021-2032)
  7. 7.4.1 Global Donepezil for Alzheimer Sales Value by Country (2021-2026)
  8. 7.4.2 Global Donepezil for Alzheimer Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Donepezil for Alzheimer Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Donepezil for Alzheimer Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Donepezil for Alzheimer Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Donepezil for Alzheimer Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Donepezil for Alzheimer Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sun Pharmaceutical
  14. 8.3.1 Sun Pharmaceutical Company Information
  15. 8.3.2 Sun Pharmaceutical Business Overview
  16. 8.3.3 Sun Pharmaceutical Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Donepezil for Alzheimer Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Donepezil for Alzheimer Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Luoxin
  26. 8.5.1 Luoxin Company Information
  27. 8.5.2 Luoxin Business Overview
  28. 8.5.3 Luoxin Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Luoxin Donepezil for Alzheimer Product Portfolio
  30. 8.5.5 Luoxin Recent Developments
  31. 8.6 Jishengtang Pharma
  32. 8.6.1 Jishengtang Pharma Company Information
  33. 8.6.2 Jishengtang Pharma Business Overview
  34. 8.6.3 Jishengtang Pharma Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jishengtang Pharma Donepezil for Alzheimer Product Portfolio
  36. 8.6.5 Jishengtang Pharma Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Donepezil for Alzheimer Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Hansoh Pharma
  44. 8.8.1 Hansoh Pharma Company Information
  45. 8.8.2 Hansoh Pharma Business Overview
  46. 8.8.3 Hansoh Pharma Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hansoh Pharma Donepezil for Alzheimer Product Portfolio
  48. 8.8.5 Hansoh Pharma Recent Developments
  49. 8.9 Dr Reddy's Laboratories
  50. 8.9.1 Dr Reddy's Laboratories Company Information
  51. 8.9.2 Dr Reddy's Laboratories Business Overview
  52. 8.9.3 Dr Reddy's Laboratories Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Dr Reddy's Laboratories Donepezil for Alzheimer Product Portfolio
  54. 8.9.5 Dr Reddy's Laboratories Recent Developments
  55. 8.10 Cipla
  56. 8.10.1 Cipla Company Information
  57. 8.10.2 Cipla Business Overview
  58. 8.10.3 Cipla Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cipla Donepezil for Alzheimer Product Portfolio
  60. 8.10.5 Cipla Recent Developments
  61. 8.11 ARK PHA.LTD
  62. 8.11.1 ARK PHA.LTD Company Information
  63. 8.11.2 ARK PHA.LTD Business Overview
  64. 8.11.3 ARK PHA.LTD Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ARK PHA.LTD Donepezil for Alzheimer Product Portfolio
  66. 8.11.5 ARK PHA.LTD Recent Developments
  67. 8.12 Apotex
  68. 8.12.1 Apotex Company Information
  69. 8.12.2 Apotex Business Overview
  70. 8.12.3 Apotex Donepezil for Alzheimer Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Apotex Donepezil for Alzheimer Product Portfolio
  72. 8.12.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Donepezil for Alzheimer Value Chain Analysis
  2. 9.1.1 Donepezil for Alzheimer Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Donepezil for Alzheimer Sales Mode & Process
  6. 9.2 Donepezil for Alzheimer Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Donepezil for Alzheimer Distributors
  9. 9.2.3 Donepezil for Alzheimer Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst